Clinical outcome measures following plasma exchange for MG exacerbation

Abstract Our objective is to report longitudinal results of the MG‐ADL, MG‐Composite, MG‐MMT, and MG‐QoL15 in an open‐label trial of therapeutic plasma exchange in myasthenia gravis. Ten MG patients experiencing exacerbation had assessments prior to, immediately following, and at selected time point...

Full description

Bibliographic Details
Main Authors: Shruti M. Raja, James F. Howard Jr, Vern C. Juel, Janice M. Massey, Manisha Chopra, Jeffrey T. Guptill
Format: Article
Language:English
Published: Wiley 2019-10-01
Series:Annals of Clinical and Translational Neurology
Online Access:https://doi.org/10.1002/acn3.50901

Similar Items